Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)-Reference-Cited by-同舟云学术

Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)

Published:2013-02-11 Issue:7 Volume:107 Page:741-745
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Iwasaki Yoshiaki,Sasako Mitsuru,Yamamoto Seiichiro,Nakamura Kenichi,Sano Takeshi,Katai Hitoshi,Tsujinaka Toshimasa,Nashimoto Atsushi,Fukushima Norimasa,Tsuburaya Akira,

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference17 articles.

1. Chemotherapy for metastatic gastric cancer: Past, present, and future;Ohtsu;J Gastroenterol,2008

2. Chemotherapy for metastatic gastric cancer in Japan;Boku;Int J Clin Oncol,2008

3. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer;Sano;N Engl J Med,2008

4. Neoadjuvant chemotherapy for gastric cancer: Indication and trial setting (in Japanese);Sasako;Shokakigeka,1992

5. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional dataset;Gastric Cancer;2024-08-22

2. Recent efficacy and safety analysis of neoadjuvant therapy with Tislelizumab combined with Apatinib and chemotherapy in Borrmann type IV, large Borrmann type III, and Bulky N locally advanced gastric cancer(3-B).;2024-07-01

3. Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial;Gastric Cancer;2024-03-08

4. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration;Chinese Clinical Oncology;2024-02

5. Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study);Gastric Cancer;2024-01-19